TBI, etoposide, and cyclophosphamide conditioning for intermediate-risk relapsed childhood acute lymphoblastic leukemia.
Hideaki UekiChitose OgawaHiroaki GotoMasanori NishiJunko YamanakaShinji MochizukiTakuro NishikawaTadashi KumamotoRitsuo NishiuchiAtsushi KikutaShohei YamamotoShunji IgarashiAtsushi SatoToshinori HoriAkiko M SaitoTomoyuki WatanabeTakao DeguchiAtsushi ManabeKeizo HoribeHidemi ToyodaPublished in: International journal of hematology (2024)
Allo-HSCT based on post-induction MRD with TBI + ETP + CY conditioning was feasible in Japanese children with intermediate-risk relapsed ALL.